CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Por um escritor misterioso

Last updated 01 janeiro 2025

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Frontiers The role of DC-SIGN as a trans-receptor in infection by MERS-CoV

Viruses, Free Full-Text

Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission - ScienceDirect

Frontiers Depletion and Dysfunction of Dendritic Cells: Understanding SARS -CoV-2 Infection

Biology, Free Full-Text

Single-Molecule Analysis of SARS-CoV-2 Binding to C-Type Lectin Receptors

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Neuropilins: C-end rule peptides and their association with nociception and COVID-19 - Computational and Structural Biotechnology Journal

Frontiers Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation

IJMS, Free Full-Text

Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors - ScienceDirect

Recomendado para você